Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 728 INR 0.4% Market Closed
Market Cap: 4.1T INR

Relative Value

The Relative Value of one SUNPHARMA stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 728 INR, Sun Pharmaceutical Industries Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SUNPHARMA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
20
vs Industry
17
Median 3Y
7.4
Median 5Y
5.9
Industry
2.6
Forward
7.2
vs History
44
vs Industry
12
Median 3Y
37.6
Median 5Y
38.7
Industry
21.4
Forward
35.5
vs History
31
vs Industry
13
Median 3Y
32.5
Median 5Y
29.6
Industry
16.4
vs History
73
vs Industry
13
Median 3Y
38.7
Median 5Y
45.2
Industry
22.8
vs History
31
vs Industry
11
Median 3Y
5.4
Median 5Y
4.6
Industry
2.2
vs History
25
vs Industry
17
Median 3Y
6.9
Median 5Y
5.5
Industry
2.9
Forward
6.7
vs History
26
vs Industry
22
Median 3Y
8.7
Median 5Y
7.4
Industry
5.5
vs History
33
vs Industry
13
Median 3Y
24.8
Median 5Y
21.4
Industry
13
Forward
23.4
vs History
33
vs Industry
13
Median 3Y
29.8
Median 5Y
27.1
Industry
16.5
Forward
28.3
vs History
33
vs Industry
14
Median 3Y
30.2
Median 5Y
28
Industry
15.6
vs History
20
vs Industry
14
Median 3Y
39.4
Median 5Y
34.6
Industry
18.7
vs History
30
vs Industry
12
Median 3Y
5.7
Median 5Y
4.2
Industry
1.9

Multiples Across Competitors

SUNPHARMA Competitors Multiples
Sun Pharmaceutical Industries Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
4.1T INR 7.5 39.7 24.4 29.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
IN
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Average P/E: 26
39.7
12%
3.3
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Average EV/EBITDA: 402
24.4
12%
2
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Average EV/EBIT: 1 714.8
29.5
13%
2.3
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5